Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL-009 Liposomal Gel in mild to moderate atopic dermatitis
NCT01568489Phase 2Completed
- Sponsor
- HanAll Biopharma
- Start
- Apr 2012
- Primary completion
- Jun 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of adenosylcobalamin in atopic dermatitis (AD), sponsored by HanAll Biopharma. Started Apr 2012; status: completed.
02
Drugs
adenosylcobalamin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01568489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568489.